CANBERRA, Australia (AP) - A U.S. biotechnology company announced on Tuesday the start of human trials in Australia of a vaccine for the coronarvirus with hopes of releasing a proven vaccine this year.
Novavax has begun the first phase of the trial in which 131 volunteers in the cities of ...
from www.washingtontimes.com stories: Health https://ift.tt/36rH6dk